106 related articles for article (PubMed ID: 32037548)
1. Fibroblasts-dependent invasion of podoplanin-positive cancer stem cells in squamous cell carcinoma.
Miyashita T; Neri S; Hashimoto H; Akutsu A; Sugano M; Fujii S; Ochiai A; Ishii G
J Cell Physiol; 2020 Oct; 235(10):7251-7260. PubMed ID: 32037548
[TBL] [Abstract][Full Text] [Related]
2. Single cell time-lapse analysis reveals that podoplanin enhances cell survival and colony formation capacity of squamous cell carcinoma cells.
Miyashita T; Higuchi Y; Kojima M; Ochiai A; Ishii G
Sci Rep; 2017 Jan; 7():39971. PubMed ID: 28059107
[TBL] [Abstract][Full Text] [Related]
3. Spatiotemporal characteristics of fibroblasts-dependent cancer cell invasion.
Miyashita T; Omori T; Nakamura H; Sugano M; Neri S; Fujii S; Hashimoto H; Tsuboi M; Ochiai A; Ishii G
J Cancer Res Clin Oncol; 2019 Feb; 145(2):373-381. PubMed ID: 30470886
[TBL] [Abstract][Full Text] [Related]
4. Podoplanin-expressing cancer-associated fibroblasts lead and enhance the local invasion of cancer cells in lung adenocarcinoma.
Neri S; Ishii G; Hashimoto H; Kuwata T; Nagai K; Date H; Ochiai A
Int J Cancer; 2015 Aug; 137(4):784-96. PubMed ID: 25648219
[TBL] [Abstract][Full Text] [Related]
5. Podoplanin-mediated TGF-β-induced epithelial-mesenchymal transition and its correlation with bHLH transcription factor DEC in TE-11 cells.
Wu Y; Liu Q; Yan X; Kato Y; Tanaka M; Inokuchi S; Yoshizawa T; Morohashi S; Kijima H
Int J Oncol; 2016 Jun; 48(6):2310-20. PubMed ID: 27035755
[TBL] [Abstract][Full Text] [Related]
6. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
[TBL] [Abstract][Full Text] [Related]
7. Podoplanin-positive cancer-associated fibroblasts could have prognostic value independent of cancer cell phenotype in stage I lung squamous cell carcinoma: usefulness of combining analysis of both cancer cell phenotype and cancer-associated fibroblast phenotype.
Ono S; Ishii G; Nagai K; Takuwa T; Yoshida J; Nishimura M; Hishida T; Aokage K; Fujii S; Ikeda N; Ochiai A
Chest; 2013 Apr; 143(4):963-970. PubMed ID: 23081722
[TBL] [Abstract][Full Text] [Related]
8. Podoplanin, a novel marker of tumor-initiating cells in human squamous cell carcinoma A431.
Atsumi N; Ishii G; Kojima M; Sanada M; Fujii S; Ochiai A
Biochem Biophys Res Commun; 2008 Aug; 373(1):36-41. PubMed ID: 18539139
[TBL] [Abstract][Full Text] [Related]
9. Podoplanin, ezrin, and Rho-A proteins may have joint participation in tumor invasion of lip cancer.
Assao A; Nonogaki S; Lauris JRP; Carvalho AL; Pinto CAL; Soares FA; Kowalski LP; Oliveira DT
Clin Oral Investig; 2017 Jun; 21(5):1647-1657. PubMed ID: 27628318
[TBL] [Abstract][Full Text] [Related]
10. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
Geng S; Guo Y; Wang Q; Li L; Wang J
Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
[TBL] [Abstract][Full Text] [Related]
11. Podoplanin Expression in Cancer-associated Fibroblasts Predicts Poor Prognosis in Patients with Squamous Cell Carcinoma of the Lung.
Yurugi Y; Wakahara M; Matsuoka Y; Sakabe T; Kubouchi Y; Haruki T; Nosaka K; Miwa K; Araki K; Taniguchi Y; Shiomi T; Nakamura H; Umekita Y
Anticancer Res; 2017 Jan; 37(1):207-213. PubMed ID: 28011493
[TBL] [Abstract][Full Text] [Related]
12. Podoplanin expressing cancer-associated fibroblasts in oral cancer.
Inoue H; Tsuchiya H; Miyazaki Y; Kikuchi K; Ide F; Sakashita H; Kusama K
Tumour Biol; 2014 Nov; 35(11):11345-52. PubMed ID: 25119595
[TBL] [Abstract][Full Text] [Related]
13. Podoplanin-positive fibroblasts enhance lung adenocarcinoma tumor formation: podoplanin in fibroblast functions for tumor progression.
Hoshino A; Ishii G; Ito T; Aoyagi K; Ohtaki Y; Nagai K; Sasaki H; Ochiai A
Cancer Res; 2011 Jul; 71(14):4769-79. PubMed ID: 21610106
[TBL] [Abstract][Full Text] [Related]
14. Podoplanin increases the migration of human fibroblasts and affects the endothelial cell network formation: A possible role for cancer-associated fibroblasts in breast cancer progression.
Suchanski J; Tejchman A; Zacharski M; Piotrowska A; Grzegrzolka J; Chodaczek G; Nowinska K; Rys J; Dziegiel P; Kieda C; Ugorski M
PLoS One; 2017; 12(9):e0184970. PubMed ID: 28938000
[TBL] [Abstract][Full Text] [Related]
15. Expression of podoplanin and vimentin is correlated with prognosis in esophageal squamous cell carcinoma.
Tanaka M; Kijima H; Shimada H; Makuuchi H; Ozawa S; Inokuchi S
Mol Med Rep; 2015 Sep; 12(3):4029-4036. PubMed ID: 26095281
[TBL] [Abstract][Full Text] [Related]
16. Podoplanin is a useful prognostic marker and indicates better differentiation in lung squamous cell cancer patients? A systematic review and meta-analysis.
Hu L; Zhang P; Mei Q; Sun W; Zhou L; Yin T
BMC Cancer; 2020 May; 20(1):424. PubMed ID: 32408907
[TBL] [Abstract][Full Text] [Related]
17. Recruitment of podoplanin positive cancer-associated fibroblasts in metastatic lymph nodes predicts poor prognosis in pathological N2 stage III lung adenocarcinoma.
Neri S; Ishii G; Taira T; Hishida T; Yoshida J; Nishimura M; Nagai K; Ochiai A
Ann Surg Oncol; 2012 Nov; 19(12):3953-62. PubMed ID: 22669451
[TBL] [Abstract][Full Text] [Related]
18. Interaction between oral squamous cell carcinoma cells and fibroblasts through TGF-β1 mediated by podoplanin.
Li YY; Zhou CX; Gao Y
Exp Cell Res; 2018 Aug; 369(1):43-53. PubMed ID: 29719198
[TBL] [Abstract][Full Text] [Related]
19. Positive and negative regulation of podoplanin expression by TGF-β and histone deacetylase inhibitors in oral and pharyngeal squamous cell carcinoma cell lines.
Ohta M; Abe A; Ohno F; Hasegawa Y; Tanaka H; Maseki S; Kondo E; Kurita K; Nakanishi H
Oral Oncol; 2013 Jan; 49(1):20-6. PubMed ID: 22840788
[TBL] [Abstract][Full Text] [Related]
20. Podoplanin-positive cancer-associated fibroblasts in the tumor microenvironment induce primary resistance to EGFR-TKIs in lung adenocarcinoma with EGFR mutation.
Yoshida T; Ishii G; Goto K; Neri S; Hashimoto H; Yoh K; Niho S; Umemura S; Matsumoto S; Ohmatsu H; Iida S; Niimi A; Nagai K; Ohe Y; Ochiai A
Clin Cancer Res; 2015 Feb; 21(3):642-51. PubMed ID: 25388165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
